Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Penile cancer].
Fosså SD, Jones WG, Hamers HP, van den Bogaert W. Fosså SD, et al. Among authors: van den bogaert w. Tidsskr Nor Laegeforen. 1990 Apr 30;110(11):1354-6. Tidsskr Nor Laegeforen. 1990. PMID: 1692641 Review. Norwegian.
Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Bernier J, Horiot JC, Bartelink H, Johansson KA, Cionini L, Gonzalèz Gonzalèz D, Hamers H, van den Bogaert W. Bernier J, et al. Among authors: van den bogaert w. Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):953-60. doi: 10.1016/0360-3016(95)02177-9. Int J Radiat Oncol Biol Phys. 1996. PMID: 8598375
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.
Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad W, Mueller RP, Kurtz J, Morgan DA, Dubois JB, Salamon E, Mirimanoff R, Bolla M, Van der Hulst M, Wárlám-Rodenhuis CC, Bartelink H; EORTC Radiation Oncology Group. Collette S, et al. Among authors: van der hulst m, van den bogaert w. Eur J Cancer. 2008 Nov;44(17):2587-99. doi: 10.1016/j.ejca.2008.07.032. Epub 2008 Aug 29. Eur J Cancer. 2008. PMID: 18757193 Clinical Trial.
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925).
Matzinger O, Heimsoth I, Poortmans P, Collette L, Struikmans H, Van Den Bogaert W, Fourquet A, Bartelink H, Ataman F, Gulyban A, Pierart M, Van Tienhoven G; EORTC Radiation Oncology & Breast Cancer Groups. Matzinger O, et al. Among authors: van tienhoven g, van den bogaert w. Acta Oncol. 2010;49(1):24-34. doi: 10.3109/02841860903352959. Acta Oncol. 2010. PMID: 20100142 Free article. Clinical Trial.
Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation.
Ptaszynski AM, Van den Bogaert W, Horiot JC, Poortmans P, Fourquet A, Struikmans H, Bartelink H, Pierart M, Collette L, van der Schueren E. Ptaszynski AM, et al. Among authors: van der schueren e, van den bogaert w. Acta Oncol. 1999;38 Suppl 13:19-27. doi: 10.1080/028418699432725. Acta Oncol. 1999. PMID: 10612492 Clinical Trial.
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Bing Oei S, Peterse HL, Pierart M, Poortmans PM, Struikmans H, Van den Bogaert W, Bartelink H; EORTC Radiotherapy, Breast Cancer Groups. Vrieling C, et al. Among authors: van den bogaert w. Eur J Cancer. 2003 May;39(7):932-44. doi: 10.1016/s0959-8049(03)00123-0. Eur J Cancer. 2003. PMID: 12706362 Clinical Trial.
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
Poortmans PM, Collette L, Horiot JC, Van den Bogaert WF, Fourquet A, Kuten A, Noordijk EM, Hoogenraad W, Mirimanoff RO, Pierart M, Van Limbergen E, Bartelink H; EORTC Radiation Oncology and Breast Cancer Groups. Poortmans PM, et al. Among authors: van den bogaert wf, van limbergen e. Radiother Oncol. 2009 Jan;90(1):80-5. doi: 10.1016/j.radonc.2008.07.011. Epub 2008 Aug 15. Radiother Oncol. 2009. PMID: 18707785 Clinical Trial.
165 results